tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Heather Behanna, 5 are a HOLD (26.32%), 14 are a BUY (73.68%).
Analyst Heather Behanna, currently employed carries an average stock price target met ratio of 91.67% that have a potential upside of 84.93% achieved within 314 days. Previously, Heather Behanna worked at WEDBUSH.
Heather Behanna’s has documented 41 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AKAO, Achaogen at 12-Dec-2016.
Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 5/20/2015. The price target of $25 was fulfilled within 1 day with a profit of $1.24 (4.73%) receiving and performance score of 47.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$193
$88.46 (84.62%)
$200
14 days ago
(07-Nov-2024)
41/56 (73.21%)
$67.75 (54.09%)
290
Hold
$167
$62.46 (59.75%)
$152
14 days ago
(07-Nov-2024)
6/13 (46.15%)
$41.75 (33.33%)
112
Buy
$150
$45.46 (43.49%)
$103
14 days ago
(07-Nov-2024)
3/5 (60%)
$24.75 (19.76%)
274
Buy
$205
$100.46 (96.10%)
$205
14 days ago
(07-Nov-2024)
12/25 (48%)
$79.75 (63.67%)
355
Buy
$182
$77.46 (74.10%)
$182
1 months ago
(21-Oct-2024)
16/48 (33.33%)
$54.69 (42.96%)
337
What Year was the first public recommendation made by Heather Behanna?
